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Introduction: Obesity generates a chronic, low-grade inflammation that is suggested
to contribute to cartilage degeneration. The infrapatellar fat pad (IPFP), an adipose
tissue located within the knee joint synovial capsule, may participate in this process.
However, regulatory mechanisms of pro-inflammatory mediator expression in the
IPFPare not fully understood. Cbp/p300-interacting transactivator 2 (CITED2) is ame-
chanically sensitive transcriptional regulator that exerts chondroprotective actions
on cartilage by repressing expression ofmatrixmetalloproteinases (MMPs) in chondro-
cytes. CITED2 deficiency is associated with increased differentiation of aged tendon
stem/progenitor cells into adipocytes. As adipokines andpro-inflammatorymediators
produced in the IPFP exert significant impact on joint inflammation and cartilage
breakdown in osteoarthritis (OA), we tested the hypothesis that CITED2 plays a chon-
droprotective role by, at least in part, suppressing adipogenesis andexpression of adi-
pokines and pro-inflammatory mediators in the IPFP.
Subjects and Methods: Cited2+/- and wild-type (WT) littermates (18 weeks-old,
male, nZ6/group) were subjected to normal (13.5% calories from fat) or high fat
diet (60% calories from fat) and/or subjected to moderate treadmill running
(10m/min) or control (0m/min) for 45 min. Explants of IPFPs from mice subjected
to or not subjected to treadmill running were co-cultured with cartilage from naı¨ve
WT mice. Effects of CITED2 manipulation on adipogenesis was investigated using
murine C3H10T1/2 pluripotent stem cells cultured in adipogenic induction medium.
Results: Cited2 expression decreased following a two week high fat diet in wild-
type mice, which was associated with increased expression of adipokines adipsin
and leptin, adipo-regulatory transcription factor Cebpa, proteolytic enzymes
Mmp13 and Adamts5. Cited2+/- mice on a normal diet mimicked the altered
gene expression changes observed in WT mice on a high fat diet, while Cited2+/-
mice on high fat diet further exaggerated the altered expression of these genes.
Treadmill running led to suppressed expression of adipokines, Cebpa, Pparg,
Mmp13 and Adamts5 in the IPFP in WT mice, but not in Cited2+/- mice. IPFP
from treadmill-run WT mice, co-cultured with naı¨ve WT cartilage, markedly
inhibited the expression of Mmp1, Mmp13, Adamts5, and Il1b in the cartilage.
Such effects were not observed in the cartilage co-cultured with IPFP from
Cited2+/- mice. In vitro, C3H10T1/2 cells transfected with Cited2 wild type
cDNA (WT-Cited2) exhibited significantly reduced adipocyte formation, and
reduced expression of adipocyte marker aP2, adipokines (i.e. adipsin, leptin),
and transcriptional regulators (Cebpa and Pparg), while the cells transfected
with dominant negative Cited2 mutant defective in p300 binding (DN-Cited2)
exhibited no such changes. WT-Cited2, but not DN-Cited2 transfected cells also
reduced Cebpa proteins in a p300 immuno-pull-down complex, while Pparg pro-
teins in the complex were not detected. This data indicates Cited2 represses adi-
pogenic differentiation by, at least partly, competing with Cebpa to bind to the
limited amount of co-factor p300.
Discussion and Conclusion: We identified a novel role of CITED2 in chondroprotec-
tion by suppressing expression of adipokine and pro-inflammatory mediators in the
IPFP. CITED2 plays this role, at least in part, by repressing transactivity of C/ebpa.
Furthermore, we demonstrated that loading-induced CITED2 contributed to the
anti-inflammatory and anti-obesity effects of exercise.
http://dx.doi.org/10.1016/j.jot.2016.06.06261
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Introduction and subjects: The microRNAs (miRNAs) play important roles in many
biological processes such as cell differentiation and apoptosis, so they may be
used in the diagnosis and treatment of many diseases like osteoporosis. Wnt signal-
ling pathways including b-catenin are essential for the skeletal cell proliferation and
bone formation. Low-density lipoprotein receptor-related protein (LRP) 5 and LRP6
are two important co-receptors of the Wnt signaling pathways. However, the exact
roles of these two co-receptors in the skeletal cell proliferation and bone formationare not explicit. This study was designed to evaluate the effects of strontium on the
expression levels of miRNAs and to explore their effects on skeletal cell prolifera-
tion, differentiation, adhesion, and apoptosis. The targets of these miRNAs were
also studied.
Methods: Molecular cloning, cell proliferation assay, cell apoptosis assay, quanti-
tative real-time PCR, luciferase reporter assay, immunofluorescence, western
blot, and other methods were used.
Results: Strontium altered the expression levels of miRNAs in vitro and in vivo.
miR-9-5p, miR-675-5p, and miR-138-5p impaired skeletal cell proliferation and
cell differentiation, and altered cell adhesion. miR-9-5p and miR-675-5p induced
MC3T3-E1 cell apoptosis more specifically than miR-138-5p. In addition, miR-675-
5p induced skeletal cell apoptosis by upregulating Nemo-like kinase (NLK) while
miR-9-5p inhibited ATDC5 cell apoptosis by downregulating NLK. miR-9-5p, miR-
675-5p, and miR-138-5p targeted glycogen synthase kinase 3 b (GSK3b), ATPase
Aminophospholipid Transporter Class I Type 8A Member 2 (ATP8A2), and Eukaryotic
Translation Initiation Factor 4E Binding Protein 1 (EIF4EBP1), respectively. LRP5
promoted skeletal cell proliferation through negatively regulating miR-675-5p
and miR-9-5p. Loss of function of LRP5 resulted in drastic cell apoptosis, increased
negative regulators of osteogenesis, and impaired cell adhesion. Strontium stabi-
lized b-catenin through increasing phosphorylation of LRP6 rather than the levels
of LRP6.
Discussion and conclusion: miR-9-5p, miR-675-5p, and miR-138-5p impaired skel-
etal cell proliferation and differentiation, and altered cell adhesion and apoptosis.
Loss of function of LRP5 resulted in impaired osteogenesis.
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Introduction: Osteoarthritis (OA) is the most common degenerative joint disease.
However, few drugs are available to effectively prevent or treat cartilage degen-
eration. So, as a new agent for chondroprotection, we expect Rebamipide to have
a protective effect on cartilage. Rebamipide is a protective drug used for gastric
mucosal injuries such as gastric ulcer and gastritis and also has protective effects
in a variety of tissue and organ injuries. In this study, we employed in vitro cell
culture using primary cultured chondrocytes from human knee OA and in vivo
mouse models of post-traumatic osteoarthritis to examine the effects of Rebami-
pide on articular cartilage degeneration.
Subjects and Methods: Chondrocytes from patients who underwent total knee
arthroplasty were isolated and plated on 6-well tissue culture plates. Cells were stim-
ulated with recombinant human IL-1b, and then treated with or without Rebamipide
for 24h. The levels of mRNA expression of COL2A, IL-1b, TNF, NF-kB, MMP3, MMP13,
ADAMTS5, TIMP3, bFGF, and TGF were estimated using real-time PCR (between six
to nine samples per gene). The mRNA levels were normalized by GAPDH levels of
each sample. Statistical significance was determined using the Kruskal-Wallis test.
Forty eight-week-old male BALB/c strain mice were used. The anterior cruciate liga-
ment andmedial collateral ligamentwere transected inboth knees (PTOA). The knees
were divided into four groups. The concentrations of Rebamipide were 0 (A), 0.1mg/
kg (B), 1mg/kg (C), and 10mg/kg (D). Mice were injected with Rebamipide into the
knee joint every week. Mice were sacrificed at six weeks after operation. All samples
were underwent haematoxylin and eosin (H-E) staining and safranin-O staining, and
evaluated using the Mankin scoring system and OARSI grading system.
Results: The mRNA expression of COL2A was significantly up-regulated after the
treatment with 500mM and 2500mM of Rebamipide. TIMP3, TGF, bFGFwere also signif-
icantly up-regulated after the treatment with 2500mM of Rebamipide. IL-1b, TNF, NF-
kB, andMMP13were significantly down-regulatedafter the treatmentwith 500mMand
2500mM of Rebamipide. MMP3 and ADAMTS5 were also significantly down-regulated
after the treatment with 2500mM of Rebamipide. Proteoglycan loss and alterations
in surface structurewere observed inA and B, but the articular cartilage hada smooth
surface in C and D. In Mankin scoring system and OARSI grading system, average his-
tological scores were significantly better in C and D than in A.
Discussion and Conclusion: This study demonstrated that Rebamipide up-regulated
the mRNA expression of COL2A and anabolic factors (TIMP3, TGF and bFGF) in
